Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
East Coast Biotech Roundup: Yumanity, Biogen, Blizzards, & More 01/30/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
NPS Pharma’s Long Road Ends With a $5.2B Shire Buyout 01/11/15 New York
East Coast Biotech Roundup: Yumanity, Padlock, CAR-T Fever, & More 12/19/14 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
East Coast Biotech Roundup: PureTech, Celgene, Unum, Biogen & More 10/24/14 Boston
East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More 09/15/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
NPS Pharma’s Francois Nader on the Megadeal Fallout for Biotechs 05/08/14 New York
10 Takeaways From New York’s Life Science Disruptors 03/10/14 New York
See You Tomorrow at New York’s Life Science Disruptors 03/05/14 New York
East Coast Biotech Roundup: HART, CoStim, Forest/Actavis, & More 02/21/14 Boston
Eric Schadt, Acorda’s Cohen Join NY’s Life Science Disruptors Lineup 01/30/14 New York
East Coast Biotech Roundup: Enanta, NY Disruptors, Repligen, & More 01/24/14 Boston
Join Us, And New York’s “Life Science Disruptors,” On March 6 01/23/14 New York
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More 08/09/13 New York
East Coast Life Sciences Roundup: Regeneron, Actavis, NPS, & More 05/24/13 Boston
Ironwood, NPS Pharma Tap Wall Street To Roll Out Lead Drugs 05/22/13 Boston
Fighting a Global War on Rare Diseases 03/20/13 New York
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
NPS Wins First FDA Approval, for Short Bowel Syndrome Drug 12/21/12 New York
East Coast Life Sciences Roundup: Orphan Drugs, Financings, More 10/19/12 New York
Biotech Racking Up Successes Against Ultra-Orphan Diseases 10/15/12 New York
NPS Rejiggers Amgen Deal, Sees $75M Extra Cash 07/02/12 New York
NPS Rallies as Good News Flows for Two Rare-Disease Drugs 06/25/12 New York
Page 1 of 2 next page »